Entera Bio Ltd.
Entera Bio develops oral peptide and protein replacement therapies using its N-Tab® technology platform.
8-KNov 16Latest SEC filing
Nov 6Latest story
November 2026
October 2026
August 2026
July 2026
Entera Bio develops oral peptide and protein replacement therapies using its N-Tab® technology platform.
November 2026
October 2026
August 2026
July 2026